NEW YORK (GenomeWeb) – OvaGene and Indian life sciences firm iLife Discoveries today announced an alliance to bring gene-based assays targeting ovarian, endometrial, and cervical cancer to India.

Initially, the partners will validate and commercialize novel assays that clinicians can use to evaluate therapeutic alternatives. Eventually, they also plan to offer expanded diagnostic and predictive services, Irvine, Calif.-based OvaGene said.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.